Article Details

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Retrieved on: 2024-01-16 21:40:59

Tags for this article:

Click the tags to see associated articles and topics

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook. View article details on hiswai:

Excerpt

A proprietary non-gene editing technology platform based on multiplexing of short hairpin ribonucleic acid (shRNAs)-derived sequences to broaden the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up